arrow
K

Katie Morgan

University of Edinburgh
H指数:7
被引数:267
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19

代谢功能障碍相关的脂肪性肝病和致死性新型冠状病毒肺炎患者肝血管紧张素转换酶2的表达

2024-08-212
OAAI
Metabolism of Acetaminophen by Enteric Epithelial Cells Mitigates Hepatocellular Toxicity In Vitro
2023-06-122
OAAI
Oxygen Plasma Substrate and Specific Nanopattern Promote Early Differentiation of HepaRG Progenitors
2020-10-012
OAAI
SARS-CoV-2 Infection and the Liver
2020-05-3032
OAAI
Validation of Reference Genes for Gene Expression Studies by RT-qPCR in HepaRG Cells during Toxicity Testing and Disease Modelling
CELLS
IF5.2
2020-03-215
OAAI
Application of Impedance-Based Techniques in Hepatology Research
2019-12-2412
OAAI
Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line
2019-03-0128
OAAI
Letter to the editor: 'Human based systems: Mechanistic NASH modelling just around the corner?'
2018-11-010
OAAI
Towards understanding the mechanisms of chlorpromazine-induced hepatic toxicity using a human HepaRG-based model
2018-04-011
PREAI
Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver
2017-01-3033
OAAI
MECHANISTIC INSIGHT INTO ACETAMINOPHEN-INDUCED HEPATIC TIGHT JUNCTION DISRUPTION USING A HUMAN HepaRG-BASED LIVERBIOCHIP IMPEDANCE BIOSENSOR
2015-04-010
PREAI
INVESTIGATING PARACETAMOL TOXICITY IN HepaRG-BASED 3D HUMAN HEPATIC ORGANOTYPIC MODELS WITH NON-INVASIVE OPTICAL COHERENCE PHASE MICROSCOPY (OCPM)
2015-04-010
PREAI
HUMAN HEPATIC HepaRG CELLS MAINTAIN HIGH INTRINSIC CYP450 ACTIVITY/METABOLISM AND SIGNIFICANTLY OUTPERFORM STANDARD HepG2/C3A CELLS USED IN DRUG PHARMACOLOGY APPLICATIONS
2014-04-010
OAAI